-
disease states to optimize doses, dosage regimens and study designs throughout all phases (first-in-human through post-approval) of clinical drug development. With guidance, identify opportunities where
-
activities. The successful candidate will be team oriented, have a passion for excellence, act with integrity, demonstrate equity and inclusivity, seek continuous improvement opportunities, and actively
-
immunoassays related to Influenza and other respiratory viruses. Additional knowledge on viral vaccination in human and animal models is highly desirable. The incumbent should possess a strong scientific
-
research with minimal supervision. Experience with human and murine neuronal cell culture and assay development Expertise in Lipid loading and related pathway analysis Expertise in core molecular biology
-
wide range (non-routine) complex audits (minimal to no oversight - as needed). Execute audit strategy and lead process audits. Act as a reviewer of audit reports from outsourced or routine audits. Assess
-
salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer
-
on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations
-
support exploration of novel therapies. Conduct in vivo studies to evaluate and establish efficacy, PK/PD relationship, combination strategy, biomarker identification and analysis. Perform ancillary in
-
eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and
-
first in human (FIH) through proof of concept (PoC) studies, including proof of mechanism (PoM) and early signals of efficacy (ESoE) studies in a given therapeutic area. The primary therapeutic areas